E-LIB Suche - Ergebnisse für: Edeki, Timi

1

Phase I Study Assessing the Pharmacokinetic Profile, Safety..:

Bradley, John S. ; Armstrong, Jon ; Arrieta, Antonio...
Antimicrobial Agents and Chemotherapy. 60 (2016) 10 - p. 6252-6259 , 2016

Link: https://doi.org/10.1128/..

2

Evaluation of the pharmacokinetics and safety of single and..:

Yang, Li ; Sunzel, Maria ; Xu, Peng...
Int. Journal of Clinical Pharmacology and Therapeutics. 53 (2015) 8 - p. 681-691 , 2015

Link: https://doi.org/10.5414/..

3

An open-label, non-randomised, phase 1, single-dose study t..:

Sunzel, Maria ; Learoyd, Maria ; Li, Jianguo...
International Journal of Antimicrobial Agents. 46 (2015) 6 - p. 682-688 , 2015

Link: https://doi.org/10.1016/..

4

A Randomized, Phase I Study to Assess the Safety, Tolerabil..:

Li, Jianguo ; Learoyd, Maria ; Qiu, Furong..
Clinical Drug Investigation. 36 (2015) 2 - p. 119-126 , 2015

Link: https://doi.org/10.1007/..

5

Phase I study assessing the safety, tolerability, and pharm..:

Tominaga, Nobumitsu ; Edeki, Timi ; Li, James...
Journal of Infection and Chemotherapy. 21 (2015) 8 - p. 551-558 , 2015

Link: https://doi.org/10.1016/..

6

Randomized pharmacokinetic and drug–drug interaction studie..:

Das, Shampa ; Li, Jianguo ; Armstrong, Jon..
Pharmacology Research & Perspectives. 3 (2015) 5 - p. , 2015

Link: https://doi.org/10.1002/..

7

Phase 1 study assessing the steady-state concentration of c..:

Nicolau, David P. ; Siew, Leonard ; Armstrong, Jon...
Journal of Antimicrobial Chemotherapy. 70 (2015) 10 - p. 2862-2869 , 2015

Link: https://doi.org/10.1093/..

8

Safety, local tolerability and pharmacokinetics of ceftarol..:

Edeki, Timi ; Kujacic, Mirjana ; Broadhurst, Helen..
British Journal of Clinical Pharmacology. 78 (2014) 6 - p. 1291-1297 , 2014

Link: https://doi.org/10.1111/..

9

Randomized, placebo-controlled study to assess the impact o..:

Das, Shampa ; Armstrong, Jon ; Mathews, David..
The Journal of Clinical Pharmacology. 54 (2013) 3 - p. 331-340 , 2013

Link: https://doi.org/10.1002/..

10

A placebo-controlled, double-blind, dose-escalation study t..:

Morris, Peter E ; Zeno, Brian ; Bernard, Andrew C...
Critical Care. 16 (2012) 1 - p. R31 , 2012

Link: https://doi.org/10.1186/..

11

PhRMA Survey on the Conduct of First‐in‐Human Clinical Tria..:

Karara, Adel H. ; Edeki, Timi ; McLeod, James..
The Journal of Clinical Pharmacology. 50 (2010) 4 - p. 380-391 , 2010

Link: https://doi.org/10.1177/..

12

PhRMA White Paper on ADME Pharmacogenomics:

Williams, J. Andrew ; Andersson, Tommy ; Andersson, Tommy B....
The Journal of Clinical Pharmacology. 48 (2008) 7 - p. 849-889 , 2008

Link: https://doi.org/10.1177/..

13

Evaluation of the potential for pharmacokinetic interaction..:

Gustavson, Linda E. ; Schweitzer, Sarah M. ; Burt, David A....
Clinical Therapeutics. 28 (2006) 3 - p. 373-387 , 2006

Link: https://doi.org/10.1016/..

14

EFFECTS OF INDIVIDUAL GINSENOSIDES, GINKGOLIDES AND FLAVONO..:

He, Nu ; Xie, Hong‐Guang ; Collins, Xavier..
Clinical and Experimental Pharmacology and Physiology. 33 (2006) 9 - p. 813-815 , 2006

Link: https://doi.org/10.1111/..

15

A Phase I Multiple‐Dose Escalation Study Characterizing Pha..:

Karyekar, Chetan S. ; Pradhan, Rajendra S. ; Freeney, Tony...
The Journal of Clinical Pharmacology. 45 (2005) 8 - p. 910-918 , 2005

Link: https://doi.org/10.1177/..